• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: C. Bradford Koenig was granted 181 units of Common Stock, increasing direct ownership by 0.91% to 20,150 units

    3/16/21 4:21:27 PM ET
    $HCXY
    Get the next $HCXY alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Koenig Bradford C.

    (Last) (First) (Middle)
    400 HAMILTON AVENUE SUITE 310

    (Street)
    PALO ALTO CA 94301

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Hercules Capital, Inc. [ HTGC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    03/15/2021
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 03/15/2021 A 181(1) A $16.6 20,150 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Shares acquired through the Hercules Capital, Inc. Dividend Reinvestment Plan.
    /s/ /Melanie Grace, Attorney-in-Fact for Bradford C. Koenig 03/16/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HCXY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCXY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HCXY
    SEC Filings

    View All

    SEC Form 8-K filed

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    3/8/21 7:00:33 AM ET
    $HCXY

    SEC Form 8-K filed

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    3/4/21 4:48:30 PM ET
    $HCXY

    SEC Form 8-K filed

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    2/23/21 4:40:42 PM ET
    $HCXY

    $HCXY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Scott Bluestein sold $1,264,000 worth of Common Stock (80,000 units at $15.80), decreasing direct ownership by 8% to 923,086 units

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    3/19/21 5:10:03 PM ET
    $HCXY

    SEC Form 4: Melanie Grace was granted 513 units of Restricted Stock Units, disposed of $166 worth of Restricted Stock Units (10 units at $16.60), disposed to the issuer $1,361 worth of Restricted Stock Units (82 units at $16.60), was granted 82 units of Common Stock and disposed of $681 worth of Common Stock (41 units at $16.60), increasing direct ownership by 188% to 64,807 units

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    3/17/21 6:05:31 PM ET
    $HCXY

    SEC Form 4: Scott Bluestein disposed of $10,607 worth of Common Stock (639 units at $16.60), was granted 4,958 units of Restricted Stock Units, disposed of $1,096 worth of Restricted Stock Units (66 units at $16.60), disposed to the issuer $23,904 worth of Restricted Stock Units (1,440 units at $16.60) and was granted 1,440 units of Common Stock, increasing direct ownership by 355% to 1,003,086 units

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    3/17/21 6:04:43 PM ET
    $HCXY

    $HCXY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. ("KBRA") has affirmed Hercules' investment grade corporate and credit rating of BBB+. KBRA issued a statement announcing the affirmation of the rating and stable outlook, as well as its underlying analysis. The affirmed BBB+ rating reflects the Company's diversified investment portfolio with a focus on senior secured first lien venture debt investments in the technology

    8/19/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Reports Second Quarter 2025 Financial Results

    Q2 2025 Total Gross Debt and Equity Commitments of $1.0 Billion Record Q2 2025 Total Gross Fundings of $709.1 Million Record 1H 2025 Total Gross Debt and Equity Commitments of $2.02 Billion Record 1H 2025 Total Gross Fundings of $1.25 Billion Record Q2 2025 Net Investment Income "NII" of $88.7 Million Q2 2025 NII of $0.50 per Share provides 125% Coverage of the Base Cash Distribution Closed Upsized Offering of $350.0 Million of 6.000% Unsecured Notes due 2030 Renewed and Increased Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 95.0% and Net Regulatory Leverage of 78.7%(1) Inclusive of the Adviser F

    7/31/25 4:07:00 PM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2025

    The Total Cash Distribution of $0.47 per Share for the Second Quarter 2025 is Comprised of a $0.40 per Share Base Distribution and a $0.07 per Share Supplemental Distribution Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a second quarter 2025 total cash distribution of $0.47 per share. The following shows the key dates of the second quarter 2025 distribution payment: Record Date August 12, 2025 Payment

    7/29/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HCXY
    Leadership Updates

    Live Leadership Updates

    View All

    Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an independent member of its board of directors, effective September 21, 2023. Mr. Theodosopoulos is an experienced corporate executive and board director with more than 38 years in senior management roles in both the financial services and technology industries. Mr. Theodosopoulos will serve on the Company's Audit Committee. "Nikos' combined experienc

    9/25/23 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Announces the Appointment of Ms. DeAnne Aguirre to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that DeAnne Aguirre was appointed to serve as an independent member of its board of directors, effective June 23, 2022. Ms. Aguirre is an experienced corporate executive and Board Director with more than 30 years in senior leadership managing large and complex domestic and international business units. Ms. Aguirre will serve on the Nominating and Corporate Governance Committee. "As we continue to expand o

    6/24/22 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Pam Randhawa was appointed to serve as a member of its board of directors, effective November 1, 2021. Ms. Randhawa is a thought leader within the life sciences sector and an experienced industry executive, with more than 20 years of experience leading public and private companies, ranging from biotech, healthcare and sustainable solutions, through their various stages of growth. Ms. Randhawa will ser

    10/20/21 6:00:00 AM ET
    $HCXY
    $HTGC
    $MCK
    Investment Managers
    Finance
    Other Pharmaceuticals
    Health Care

    $HCXY
    Financials

    Live finance-specific insights

    View All

    Hercules Capital Reports Second Quarter 2025 Financial Results

    Q2 2025 Total Gross Debt and Equity Commitments of $1.0 Billion Record Q2 2025 Total Gross Fundings of $709.1 Million Record 1H 2025 Total Gross Debt and Equity Commitments of $2.02 Billion Record 1H 2025 Total Gross Fundings of $1.25 Billion Record Q2 2025 Net Investment Income "NII" of $88.7 Million Q2 2025 NII of $0.50 per Share provides 125% Coverage of the Base Cash Distribution Closed Upsized Offering of $350.0 Million of 6.000% Unsecured Notes due 2030 Renewed and Increased Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 95.0% and Net Regulatory Leverage of 78.7%(1) Inclusive of the Adviser F

    7/31/25 4:07:00 PM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Announces Date for Release of Second Quarter 2025 Financial Results and Conference Call

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2025 financial results conference call for Thursday, July 31, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of our website at inves

    7/17/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Announces Date of 2025 Annual Meeting of Stockholders

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), will conduct its 2025 Annual Meeting of Stockholders by virtual meeting on Wednesday, June 18, 2025 at 9:00 a.m. (Eastern Time). The proxy statement for the meeting was filed on April 24, 2025 and mailed to stockholders of record as of April 17, 2025. 2025 Annual Meeting of Stockholders June 18, 2025 at 9:00 a.m. Eastern Time Virtual Meeting via Internet: http://www.virtualshareholdermeeting.com/HTGC2025 Matters to be voted on include: 1) election of three directors, 2) an advisory vote on the compensation of the Company's named executive officers, 3) authorization of the Company to sell or issue shares of its common stock

    5/8/25 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HCXY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed

    SC 13G - Hercules Capital, Inc. (0001280784) (Subject)

    2/17/21 2:27:11 PM ET
    $HCXY